1,320
Views
15
CrossRef citations to date
0
Altmetric
Drug Evaluations

Optimal airway antimicrobial therapy for cystic fibrosis: the role of inhaled aztreonam lysine

, MD & , MD
Pages 1373-1385 | Published online: 29 Apr 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yagmur Akdag Cayli, Selma Sahin, Francesca Buttini, Anna Giulia Balducci, Serena Montanari, Imran Vural & Levent Oner. (2017) Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients. Drug Development and Industrial Pharmacy 43:8, pages 1378-1389.
Read now

Articles from other publishers (14)

Sandra Anderson, Paul Atkins, Per Bäckman, David Cipolla, Andrew Clark, Evangelia Daviskas, Bernd Disse, Plamena Entcheva-Dimitrov, Rick Fuller, Igor Gonda, Hans Lundbäck, Bo Olsson & Jeffry Weers. (2022) Inhaled Medicines: Past, Present, and Future. Pharmacological Reviews 74:1, pages 48-118.
Crossref
Kathryn McLean, Duankun Lee, Elizabeth A. Holmes, Kelsi Penewit, Adam Waalkes, Mingxin Ren, Samuel A. Lee, Joseph Gasper, Colin Manoil & Stephen J. Salipante. (2019) Genomic Analysis Identifies Novel Pseudomonas aeruginosa Resistance Genes under Selection during Inhaled Aztreonam Therapy In Vivo . Antimicrobial Agents and Chemotherapy 63:9.
Crossref
Arcadia Woods & Khondaker Miraz Rahman. (2018) Antimicrobial molecules in the lung: formulation challenges and future directions for innovation. Future Medicinal Chemistry 10:5, pages 575-604.
Crossref
George A. O'Toole. (2018) Cystic Fibrosis Airway Microbiome: Overturning the Old, Opening the Way for the New. Journal of Bacteriology 200:4.
Crossref
Jeffry Weers. (2015) Inhaled antimicrobial therapy – Barriers to effective treatment. Advanced Drug Delivery Reviews 85, pages 24-43.
Crossref
Aukje C. Bos, Cedric van Holsbeke, Jan W. de Backer, Mireille van Westreenen, Hettie M. Janssens, Wim G. Vos & Harm A. W. M. Tiddens. (2015) Patient-Specific Modeling of Regional Antibiotic Concentration Levels in Airways of Patients with Cystic Fibrosis: Are We Dosing High Enough?. PLOS ONE 10:3, pages e0118454.
Crossref
Axel Dalhoff. (2014) Pharmacokinetics and Pharmacodynamics of Aerosolized Antibacterial Agents in Chronically Infected Cystic Fibrosis Patients. Clinical Microbiology Reviews 27:4, pages 753-782.
Crossref
J.-C. Dubus, L. Bassinet, F. Chedevergne, B. Delaisi, N. Desmazes-Dufeu, G. Reychler & L. Vecellio. (2014) Mucoviscidose et traitements inhal?s?: quoi de neuf en 2013??. Revue des Maladies Respiratoires 31:4, pages 336-346.
Crossref
Q. Yu, E. F. Griffin, S. Moreau-Marquis, J. D. Schwartzman, B. A. Stanton & G. A. O'Toole. (2012) In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells. Journal of Antimicrobial Chemotherapy 67:11, pages 2673-2681.
Crossref
Lev Ruzer & Naomi HarleyStephen Marek, Hugh Smyth, Lucila Garcia-Contreras, Daniel Cooney, Robert Garmise, Latarsha Jones & Anthony Hickey. 2012. Aerosols Handbook. Aerosols Handbook 1 30 .
Kristen Zeitler, Brian Salvas, Vanessa Stevens & Jack Brown. (2012) Aztreonam lysine for inhalation: New formulation of an old antibiotic. American Journal of Health-System Pharmacy 69:2, pages 107-115.
Crossref
Ryan Hudson & Brooke Olson Blair. (2011) Inhaled antibiotics for Gram-negative respiratory infections. Future Medicinal Chemistry 3:13, pages 1663-1677.
Crossref
HELEN K. REDDEL, T. K. LIM, MICHIAKI MISHIMA, CLAIRE E. WAINWRIGHT & DARRYL A. KNIGHT. (2011) Year-in-review 2010: Asthma, COPD, cystic fibrosis and airway biology. Respirology 16:3, pages 540-552.
Crossref
David Berlana, Josep Manel Llop, Frederic Manresa & Ramón Jódar. (2012) Outpatient Treatment of Pseudomonas aeruginosa Bronchial Colonization with Long‐term Inhaled Colistin, Tobramycin, or Both in Adults without Cystic Fibrosis . Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31:2, pages 146-157.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.